- Home
- BMY vs SYK Comparison
BMY vs SYK Comparison
Compare BMY & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- SYK
- Stock Information
- Founded
- BMY 1887
- SYK 1941
- Country
- BMY United States
- SYK United States
- Employees
- BMY N/A
- SYK N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- SYK Medical/Dental Instruments
- Sector
- BMY Health Care
- SYK Health Care
- Exchange
- BMY Nasdaq
- SYK Nasdaq
- Market Cap
- BMY 120.5B
- SYK 141.0B
- IPO Year
- BMY N/A
- SYK N/A
- Fundamental
- Price
- BMY $59.59
- SYK $377.39
- Analyst Decision
- BMY Hold
- SYK Buy
- Analyst Count
- BMY 14
- SYK 20
- Target Price
- BMY $58.00
- SYK $420.68
- AVG Volume (30 Days)
- BMY 12.2M
- SYK 1.6M
- Earning Date
- BMY 04-24-2025
- SYK 04-29-2025
- Dividend Yield
- BMY 4.16%
- SYK 0.89%
- EPS Growth
- BMY N/A
- SYK N/A
- EPS
- BMY N/A
- SYK 7.76
- Revenue
- BMY $48,300,000,000.00
- SYK $22,595,000,000.00
- Revenue This Year
- BMY N/A
- SYK $10.19
- Revenue Next Year
- BMY N/A
- SYK $6.69
- P/E Ratio
- BMY N/A
- SYK $48.11
- Revenue Growth
- BMY 7.32
- SYK 10.23
- 52 Week Low
- BMY $39.35
- SYK $314.93
- 52 Week High
- BMY $63.33
- SYK $406.19
- Technical
- Relative Strength Index (RSI)
- BMY 50.17
- SYK 51.99
- Support Level
- BMY $58.23
- SYK $361.03
- Resistance Level
- BMY $61.64
- SYK $374.20
- Average True Range (ATR)
- BMY 1.45
- SYK 7.81
- MACD
- BMY -0.16
- SYK 0.76
- Stochastic Oscillator
- BMY 39.74
- SYK 83.25
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one fourth of Stryker's total revenue currently comes from outside the United States.